Trial Profile
Clinical effectiveness of laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2013-2015.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2016
Price :
$35
*
At a glance
- Drugs Laninamivir (Primary) ; Peramivir (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Therapeutic Use
- 29 Dec 2016 New trial record
- 30 Oct 2016 Results assessing clinical efficacy of peramivir and laninamivir presented at the IDWeek 2016